Hepatitis B virus e antigen loss during adefovir dipivoxil therapy is associated with enhanced virus-specific CD4+ T-cell reactivity / Cooksley, H; Chokshi, S; Maayan, Y; Wedwmeyer, H; Andreone, P; Gilson, R; Warnes, T; Paganin, S; Zoulim, F; Frederick, D; Neumann, Au; Brosgart, Cl; Naoumov, Nv.. - In: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. - ISSN 0066-4804. - 52:1(2008), pp. 312-320. [10.1128/AAC.00467-07]

Hepatitis B virus e antigen loss during adefovir dipivoxil therapy is associated with enhanced virus-specific CD4+ T-cell reactivity

Andreone P;
2008
2008
52
1
312
320
WOS:000252133700035
2-s2.0-37849001718
17984230
Hepatitis B virus e antigen loss during adefovir dipivoxil therapy is associated with enhanced virus-specific CD4+ T-cell reactivity / Cooksley, H; Chokshi, S; Maayan, Y; Wedwmeyer, H; Andreone, P; Gilson, R; Warnes, T; Paganin, S; Zoulim, F; Frederick, D; Neumann, Au; Brosgart, Cl; Naoumov, Nv.. - In: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. - ISSN 0066-4804. - 52:1(2008), pp. 312-320. [10.1128/AAC.00467-07]
Cooksley, H; Chokshi, S; Maayan, Y; Wedwmeyer, H; Andreone, P; Gilson, R; Warnes, T; Paganin, S; Zoulim, F; Frederick, D; Neumann, Au; Brosgart, Cl; N...espandi
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1237238
Citazioni
  • ???jsp.display-item.citation.pmc??? 21
  • Scopus 47
  • ???jsp.display-item.citation.isi??? 44
social impact